Advertisement

Diagnostic Evaluation of Usual Ductal Hyperplasia and Atypical Ductal Hyperplasia

  • Anna Biernacka
  • Melinda F. Lerwill
Chapter

Abstract

Ductal hyperplasia of the breast is an intraductal proliferation of epithelial cells that is subdivided into two diagnostic categories: usual ductal hyperplasia and atypical ductal hyperplasia. Usual ductal hyperplasia represents a non-neoplastic proliferation that is commonly encountered as a component of fibrocystic changes. Atypical ductal hyperplasia, on the other hand, represents a neoplastic proliferation that shares cytologic and architectural features with ductal carcinoma in situ. Accurate differentiation between these two forms of ductal hyperplasia is important for patient management and breast cancer risk assessment.

Keywords

Usual ductal hyperplasia Atypical ductal hyperplasia Ductal carcinoma in situ Breast cancer Core biopsy Chemoprevention 

References

  1. 1.
    Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–37.CrossRefPubMedGoogle Scholar
  2. 2.
    Jabbar SB, Lynch B, Seiler S, Hwang H, Sahoo S. Pathologic findings of breast lesions detected on magnetic resonance imaging. Arch Pathol Lab Med. 2017;141:1513–22.CrossRefPubMedGoogle Scholar
  3. 3.
    Boecker W, Moll R, Dervan P, Buerger H, Poremba C, Diallo RI, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in-situ. J Pathol. 2002;198:458–67.CrossRefPubMedGoogle Scholar
  4. 4.
    Otterbach F, Bànkfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology. 2000;37:232–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698–708.CrossRefPubMedGoogle Scholar
  6. 6.
    Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the nurses’ health study. Cancer. 2006;107:1240–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010;57:171–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Simpson JF. Update on atypical epithelial hyperplasia and ductal carcinoma in situ. Pathology. 2009;41:36–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Mooney KL, Bassett LW, Apple SK. Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 2016;29:1471–84.CrossRefPubMedGoogle Scholar
  10. 10.
    Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila). 2014;7:211–7.CrossRefGoogle Scholar
  11. 11.
    Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast – risk assessment and management options. N Engl J Med. 2015;372:78–89.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012;136:627–33.CrossRefPubMedGoogle Scholar
  13. 13.
    Smith SG, Sestak I, Forster A, Partridge A, Side L, Wolf MS, et al. Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol. 2016;27:575–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson AN, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015;313:1122–32.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65:518–29.CrossRefPubMedGoogle Scholar
  16. 16.
    Schnitt SJ, Collins LC. Intraductal proliferative lesions: usual ductal hyperplasia, atypical ductal hyperplasia, and ductal carcinoma in situ. In: Biopsy Interpretation of the Breast. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013. p. 78.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PathologyThe University of Chicago Medicine and Biological SciencesChicagoUSA
  2. 2.Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations